Toor J, Li X, Jit M, Trotter CL, Echeverria-Londono S, Hartner AM, Roth J, Portnoy A, Abbas K, Ferguson NM, Am Gaythorpe K. (2022). COVID-19 impact on routine immunisations for vaccine-preventable diseases: Projecting the effect of different routes to recovery. Vaccine

Kitamura N, Abbas K, Nathwani D. (2022). Public health and social measures to mitigate the health and economic impact of the COVID-19 pandemic in Turkey, Egypt, Ukraine, Kazakhstan, and Poland during 2020-2021: situational analysis. BMC public health, 22(1)

Echeverria-Londono S, Hartner AM, Li X, Roth J, Portnoy A, Sbarra AN, Abbas K, Ferrari M, Fu H, Jit M, Ferguson NM, Gaythorpe KAM. (2022). Exploring the subnational inequality and heterogeneity of the impact of routine measles immunisation in Africa. Vaccine

Ali HA, Hartner AM, Echeverria-Londono S, Roth J, Li X, Abbas K, Portnoy A, Vynnycky E, Woodruff K, Ferguson NM, Toor J, Gaythorpe KA. (2022). Vaccine equity in low and middle income countries: a systematic review and meta-analysis. International journal for equity in health, 21(1)

Liu Y, Pearson CAB, Sandmann FG, Barnard RC, Kim JH, , Flasche S, Jit M, Abbas K. (2022). Dosing interval strategies for two-dose COVID-19 vaccination in 13 middle-income countries of Europe: Health impact modelling and benefit-risk analysis. The Lancet regional health. Europe

Portnoy A, Hsieh YL, Abbas K, Klepac P, Santos H, Brenzel L, Jit M, Ferrari M. (2022). Differential health impact of intervention programs for time-varying disease risk: a measles vaccination modeling study. BMC medicine, 20(1)

Ahmed Ali H, Hartner AM, Echeverria-Londono S, Roth J, Li X, Abbas K, Portnoy A, Vynnycky E, Woodruff K, Ferguson NM, Toor J, Gaythorpe KAM. (2022). Correction: Vaccine equity in low and middle income countries: a systematic review and meta-analysis. International journal for equity in health, 21(1)

Li X, Mukandavire C, Cucunubá ZM, Echeverria Londono S, Abbas K, Clapham HE, Jit M, Johnson HL, Papadopoulos T, Vynnycky E, Brisson M, Carter ED, Clark A, de Villiers MJ, Eilertson K, Ferrari MJ, Gamkrelidze I, Gaythorpe KAM, Grassly NC, Hallett TB, Hinsley W, Jackson ML, Jean K, Karachaliou A, Klepac P, Lessler J, Li X, Moore SM, Nayagam S, Nguyen DM, Razavi H, Razavi-Shearer D, Resch S, Sanderson C, Sweet S, Sy S, Tam Y, Tanvir H, Tran QM, Trotter CL, Truelove S, van Zandvoort K, Verguet S, Walker N, Winter A, Woodruff K, Ferguson NM, Garske T, . (2021). Estimating the health impact of vaccination against ten pathogens in 98 low-income and middle-income countries from 2000 to 2030: a modelling study. Lancet, 397(10272)

Gaythorpe KAM, Abbas K, Huber J, Karachaliou A, Thakkar N, Woodruff K, Li X, Echeverria-Londono S, , Ferrari M, Jackson M, McCarthy K, Perkins AT, Trotter C, Jit M. (2021). Impact of COVID-19-related disruptions to measles, meningococcal A, and yellow fever vaccination in 10 countries. eLife, (10)

Mayerová D, Abbas K. (2021). Childhood immunisation timeliness and vaccine confidence by health information source, maternal, socioeconomic, and geographic characteristics in Albania. BMC public health, 21(1)

Fu H, Abbas K, Klepac P, van Zandvoort K, Tanvir H, Portnoy A, Jit M. (2021). Effect of evidence updates on key determinants of measles vaccination impact: a DynaMICE modelling study in ten high-burden countries. BMC medicine, 19(1)

Abbas K, Mogasale V. (2021). Disruptions to childhood immunisation due to the COVID-19 pandemic. Lancet

Toor J, Echeverria-Londono S, Li X, Abbas K, Carter ED, Clapham HE, Clark A, de Villiers MJ, Eilertson K, Ferrari M, Gamkrelidze I, Hallett TB, Hinsley WR, Hogan D, Huber JH, Jackson ML, Jean K, Jit M, Karachaliou A, Klepac P, Kraay A, Lessler J, Li X, Lopman BA, Mengistu T, Metcalf CJE, Moore SM, Nayagam S, Papadopoulos T, Perkins TA, Portnoy A, Razavi H, Razavi-Shearer D, Resch S, Sanderson C, Sweet S, Tam Y, Tanvir H, Tran Minh Q, Trotter CL, Truelove SA, Vynnycky E, Walker N, Winter A, Woodruff K, Ferguson NM, Gaythorpe KA. (2021). Lives saved with vaccination for 10 pathogens across 112 countries in a pre-COVID-19 world. eLife, (10)

Echeverria-Londono S, Li X, Toor J, de Villiers MJ, Nayagam S, Hallett TB, Abbas K, Jit M, Klepac P, Jean K, Garske T, Ferguson NM, Gaythorpe KAM. (2021). How can the public health impact of vaccination be estimated?. BMC public health, 21(1)

Abbas K, Procter SR, Clark A, Flasche S. (2021). COVID-19's lost generation of unvaccinated children - Authors' reply. The Lancet. Global health

Portnoy A, Abbas K, Sweet S, Kim JJ, Jit M. (2021). Projections of human papillomavirus (HPV) vaccination impact in Ethiopia, India, Nigeria and Pakistan: a comparative modelling study. BMJ global health, 6(11)

Idris IO, Obwoya JG, Tapkigen J, Lamidi SA, Ochagu VA, Abbas K. (2021). Impact evaluation of immunisation service integration to nutrition programmes and paediatric outpatient departments of primary healthcare centres in Rumbek East and Rumbek Centre counties of South Sudan. Family medicine and community health, 9(3)

Abbas KM, van Zandvoort K, Brisson M, Jit M. (2020). Effects of updated demography, disability weights, and cervical cancer burden on estimates of human papillomavirus vaccination impact at the global, regional, and national levels: a PRIME modelling study. The Lancet. Global health

Abbas K, Procter SR, van Zandvoort K, Clark A, Funk S, Mengistu T, Hogan D, Dansereau E, Jit M, Flasche S,. (2020). Routine childhood immunisation during the COVID-19 pandemic in Africa: a benefit-risk analysis of health benefits versus excess risk of SARS-CoV-2 infection. The Lancet. Global health

Geweniger A, Abbas KM. (2020). Childhood vaccination coverage and equity impact in Ethiopia by socioeconomic, geographic, maternal, and child characteristics. Vaccine, 38(20)

Weaver E, Kolivras KN, Thomas RQ, Thomas VA, Abbas KM. (2020). Environmental factors affecting ecological niche of Coccidioides species and spatial dynamics of valley fever in the United States. Spatial and spatio-temporal epidemiology, (32)

Ochalek J, Abbas K, Claxton K, Jit M, Lomas J. (2020). Assessing the value of human papillomavirus vaccination in Gavi-eligible low-income and middle-income countries. BMJ global health, 5(10)

Pearson CAB, Abbas KM, Clifford S, Flasche S, Hladish TJ. (2019). Serostatus testing and dengue vaccine cost-benefit thresholds. Journal of the Royal Society, Interface, 16(157)

Singh M, Sarkhel P, Kang GJ, Marathe A, Boyle K, Murray-Tuite P, Abbas KM, Swarup S. (2019). Impact of demographic disparities in social distancing and vaccination on influenza epidemics in urban and rural regions of the United States. BMC infectious diseases, 19(1)

Abbas KM, Kang GJ, Chen D, Werre SR, Marathe A. (2018). Demographics, perceptions, and socioeconomic factors affecting influenza vaccination among adults in the United States. PeerJ, (6)

Mokdad AH, Ballestros K, Echko M, Glenn S, Olsen HE, Mullany E, Lee A, Khan AR, Ahmadi A, Ferrari AJ, Kasaeian A, Werdecker A, Carter A, Zipkin B, Sartorius B, Serdar B, Sykes BL, Troeger C, Fitzmaurice C, Rehm CD, Santomauro D, Kim D, Colombara D, Schwebel DC, Tsoi D, Kolte D, Nsoesie E, Nichols E, Oren E, Charlson FJ, Patton GC, Roth GA, Hosgood HD, Whiteford HA, Kyu H, Erskine HE, Huang H, Martopullo I, Singh JA, Nachega JB, Sanabria JR, Abbas K, Ong K, Tabb K, Krohn KJ, Cornaby L, Degenhardt L, Moses M, Farvid M, Griswold M, Criqui M, Bell M, Nguyen M, Wallin M, Mirarefin M, Qorbani M, Younis M, Fullman N, Liu P, Briant P, Gona P, Havmoller R, Leung R, Kimokoti R, Bazargan-Hejazi S, Hay SI, Yadgir S, Biryukov S, Vollset SE, Alam T, Frank T, Farid T, Miller T, Vos T, Bärnighausen T, Gebrehiwot TT, Yano Y, Al-Aly Z, Mehari A, Handal A, Kandel A, Anderson B, Biroscak B, Mozaffarian D, Dorsey ER, Ding EL, Park EK, Wagner G, Hu G, Chen H, Sunshine JE, Khubchandani J, Leasher J, Leung J, Salomon J, Unutzer J, Cahill L, Cooper L, Horino M, Brauer M, Breitborde N, Hotez P, Topor-Madry R, Soneji S, Stranges S, James S, Amrock S, Jayaraman S, Patel T, Akinyemiju T, Skirbekk V, Kinfu Y, Bhutta Z, Jonas JB, Murray CJL. (2018). The State of US Health, 1990-2016: Burden of Diseases, Injuries, and Risk Factors Among US States. JAMA, 319(14)

Kang GJ, Ewing-Nelson SR, Mackey L, Schlitt JT, Marathe A, Abbas KM, Swarup S. (2017). Semantic network analysis of vaccine sentiment in online social media. Vaccine, 35(29)

Dorratoltaj N, Nikin-Beers R, Ciupe SM, Eubank SG, Abbas KM. (2017). Multi-scale immunoepidemiological modeling of within-host and between-host HIV dynamics: systematic review of mathematical models. PeerJ, (5)

Kang GJ, Culp RK, Abbas KM. (2017). Facilitators and barriers of parental attitudes and beliefs toward school-located influenza vaccination in the United States: Systematic review. Vaccine, 35(16)

Dorratoltaj N, O'Dell ML, Bordwine P, Kerkering TM, Redican KJ, Abbas KM. (2018). Epidemiological Effectiveness and Cost of a Fungal Meningitis Outbreak Response in New River Valley, Virginia: Local Health Department and Clinical Perspectives. Disaster medicine and public health preparedness, 12(1)

Dorratoltaj N, Marathe A, Lewis BL, Swarup S, Eubank SG, Abbas KM. (2017). Epidemiological and economic impact of pandemic influenza in Chicago: Priorities for vaccine interventions. PLoS computational biology, 13(6)

Abbas KM, Dorratoltaj N, O'Dell ML, Bordwine P, Kerkering TM, Redican KJ. (2016). Clinical Response, Outbreak Investigation, and Epidemiology of the Fungal Meningitis Epidemic in the United States: Systematic Review. Disaster medicine and public health preparedness, 10(1)

Redican KJ, Abbas K, Elvinger F, Hosig K, Marmagas SW, Chitsulo P, Kelly P, Burton J, Tlou J, Carter-Tod S. Making a Difference in Malawi and Zambia Through Health Education and Public Health Best Practices. Global journal of health education and promotion, 16(2)

Abbas KM, Dorratoltaj N, O'Dell ML, Bordwine P, Kerkering TM, Redican KJ. (2015). Economic Evaluation of Fungal Meningitis Outbreak Response in New River Valley: Local Health Department Perspective. Frontiers in public health services & systems research, 4(4)

Lopez D, Gunasekaran M, Murugan BS, Kaur H, Abbas KM. (2014). Spatial Big Data Analytics of Influenza Epidemic in Vellore, India. Proceedings : ... IEEE International Conference on Big Data. IEEE International Conference on Big Data, (2014)

Kang GJ, Gunaseelan L, Abbas KM. (2014). Epidemiological Modeling of Bovine Brucellosis in India. Proceedings : ... IEEE International Conference on Big Data. IEEE International Conference on Big Data, (2014)

Abbas KM. (2014). Editorial Comment: Cost-Effectiveness Analysis for Prioritization of Limited Public Health Resources - Tuberculosis Interventions in Texas. Frontiers in public health services & systems research, 3(2)

Swanson RC, Cattaneo A, Bradley E, Chunharas S, Atun R, Abbas KM, Katsaliaki K, Mustafee N, Mason Meier B, Best A. (2012). Rethinking health systems strengthening: key systems thinking tools and strategies for transformational change. Health policy and planning, (27 Suppl 4)